Prestige Consumer Healthcare (PBH) Return on Capital Employed Growth (1y) (2012 - 2025)
Prestige Consumer Healthcare (PBH) Return on Capital Employed Growth (1y) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.82 Bn | 87.96 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 36.03 Bn | 32.29 Bn | 1.97 Bn | 696.00 |
| 3 | Zoetis | 32.48 Bn | 30.54 Bn | 1.62 Bn | -507.00 |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.50 Bn | 4.39 Bn | -723.00 |
| 5 | United Therapeutics | 23.02 Bn | 20.86 Bn | 648.10 Mn | 89.00 |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.43 Bn | 18.63 Bn | 1.16 Bn | 944.00 |
| 8 | Neurocrine Biosciences | 17.77 Bn | 16.46 Bn | 800.70 Mn | 448.00 |
| 9 | Elanco Animal Health | 12.73 Bn | 12.30 Bn | 785.00 Mn | 1,195.00 |
| 10 | Prestige Consumer Healthcare | 2.42 Bn | 2.36 Bn | 157.37 Mn | -58.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -58.00 |
| Sep 30, 2025 | -10.00 |
| Jun 30, 2025 | -12.00 |
| Mar 31, 2025 | -33.00 |
| Dec 31, 2024 | 1,091.00 |
| Sep 30, 2024 | 1,079.00 |
| Jun 30, 2024 | 1,105.00 |
| Mar 31, 2024 | 1,132.00 |
| Dec 31, 2023 | -1,010.00 |
| Sep 30, 2023 | -1,003.00 |
| Jun 30, 2023 | -1,000.00 |
| Mar 31, 2023 | -1,003.00 |
| Dec 31, 2022 | 30.00 |
| Sep 30, 2022 | 33.00 |
| Jun 30, 2022 | 9.00 |
| Mar 31, 2022 | 43.00 |
| Dec 31, 2021 | 12.00 |
| Sep 30, 2021 | -11.00 |
| Jun 30, 2021 | 21.00 |
| Mar 31, 2021 | 22.00 |